Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max O'Donnell

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Annals of the American Thoracic Society|December 2, 2017
Incorporating Markers of Disease Severity into Near Real-Time Influenza SurveillanceCarlos G Grijalva, Max O'Donnell, H Keipp Talbot
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with TuberculosisTodd Cutler, David Scales, William Levine, et al.
The European Respiratory Journal|October 13, 2018
Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic reviewStephanie Law, Amrita Daftary, Max O'Donnell, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 9, 2023
Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistanceSenamile Lale Ngema, Navisha Dookie, Rubeshan Perumal, et al.
Ebiomedicine|May 4, 2020
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatmentCamus Nimmo, Kayleen Brien, James Millard, et al.
BMC Infectious Diseases|March 25, 2026
Body mass index (BMI) at RR-TB diagnosis as an independent predictor of treatment outcomes: a retrospective analysisNonkululeko Mzinyane, Rubeshan Perumal, Lateef Babatunde Amusa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: an individual isolate metaanalysisCamus Nimmo, Neda Bionghi, Matthew J Cummings, et al.
Journal of Intensive Care Medicine|February 28, 2024
Epidemiology and Outcomes of Critical Illness and Novel Predictors of Mortality in an Ethiopian Medical Intensive Care UnitAschalew Worku, Deborah Haisch, Madhavi Parekh, et al.
Frontiers in Microbiology|July 6, 2016
Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and StreptomycinXia Yu, Yunting Gu, Guanglu Jiang, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2010
Revisiting rates of reactivation tuberculosis: a population-based approachC Robert Horsburgh, Max O'Donnell, Sandra Chamblee, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Annals of the American Thoracic Society|December 2, 2017
Incorporating Markers of Disease Severity into Near Real-Time Influenza SurveillanceCarlos G Grijalva, Max O'Donnell, H Keipp Talbot
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with TuberculosisTodd Cutler, David Scales, William Levine, et al.
The European Respiratory Journal|October 13, 2018
Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic reviewStephanie Law, Amrita Daftary, Max O'Donnell, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 9, 2023
Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistanceSenamile Lale Ngema, Navisha Dookie, Rubeshan Perumal, et al.
Ebiomedicine|May 4, 2020
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatmentCamus Nimmo, Kayleen Brien, James Millard, et al.
BMC Infectious Diseases|March 25, 2026
Body mass index (BMI) at RR-TB diagnosis as an independent predictor of treatment outcomes: a retrospective analysisNonkululeko Mzinyane, Rubeshan Perumal, Lateef Babatunde Amusa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: an individual isolate metaanalysisCamus Nimmo, Neda Bionghi, Matthew J Cummings, et al.
Journal of Intensive Care Medicine|February 28, 2024
Epidemiology and Outcomes of Critical Illness and Novel Predictors of Mortality in an Ethiopian Medical Intensive Care UnitAschalew Worku, Deborah Haisch, Madhavi Parekh, et al.
Frontiers in Microbiology|July 6, 2016
Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and StreptomycinXia Yu, Yunting Gu, Guanglu Jiang, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2010
Revisiting rates of reactivation tuberculosis: a population-based approachC Robert Horsburgh, Max O'Donnell, Sandra Chamblee, et al.
Pageof 4